The latest EAN webinar, on 'Biomarker-based etiological diagnosis of mild cognitive impairment and mild dementia' takes place on 28 October

With so few chances for EAN staff and members to meet in person, we decided to introduce the team behind the scenes. First up are Marson, from the Congress Department, and Simon, from the Communications Department.

EAN Secretary General, Elena Moro, provides an update on membership-related issues, including a range of new benefits for EAN members.

For October 2021, we have selected: Spelman T. el al Treatment Escalation vs Immediate Initiation of Highly Effective Treatment for Patients With Relapsing-Remitting Multiple Sclerosis: Data From 2 Different National Strategies.

For October 2021, we have selected: Lopez Bernal J. et al, Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant: test-negative case–control study.

Prof. Gennarina Arabia, Member of the EAN Task Force on Gender and Diversity Issues in Neurology interviews Prof. Giovannella Baggio.

Follow-up interview with Dr. Prashanth LK of the Parkinson's Disease & Movement Disorders Clinic, Bangalore

Alzheimer Europe has co-authored a paper published in Alzheimer's & Dementia: Translational Research & Clinical Interventions on identifying relevant outcomes in the progression of Alzheimer's disease

Registration is now open for the two-day Brain Innovation Days event, to be held physically in Brussels, Belgium, on 12-13 October.

EPICLUSTER will hold its 3rd activity on Accelerating Patient Involvement in European Epilepsy Research on 6 October from 9:30 to 13:00 CET

Call from the European Commission for a member representing health professionals and one alternate for the EMA's Pharmacovigilance Risk Assessment Committee (PRAC).

Breaking News by Dementia and cognitive disorders Panel

This year, at the upcoming 37th ECTRIMS congress, the ECTRIMS-EAN Session, chaired by Profs. Massimo Filippi, Mar Tintoré, Maria Pia Amato and Celia Oreja-Guevara, will discuss two key aspects of MS management: the consensus regarding vaccinations in people with MS and the updated guidelines for MS treatment.

Retrospective analysis of consecutive PD patients seen in an outpatient Movement Disorders Clinic during 2 months, to explore the frequency of ICD during the preceding 2-month lockdown period, and comparison with an equivalent control group.

In this article the authors aimed to uncover if headache patients develop more headaches after COVID-19 mRNA vaccination than healthy controls.